Drug Maker Merck Sues US Gov. Over Inflation Reduction Act
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
The war on drug prices faces a counter-offensive.
While many pharmaceutical companies have been moaning and groaning about the new regulations on the industry imposed by the Inflation Reduction Act last year, one has taken action. On Tuesday, Merck Co. filed a lawsuit against US health agencies, calling the bill's price negotiation policies a "sham" and unconstitutional.
Source Fool.com
Merck KGaA Stock
€152.85
0.030%
Our community is currently high on Merck KGaA with 3 Buy predictions and 1 Sell predictions.
However, we have a potential of -4.48% for Merck KGaA as the target price of 146 € is below the current price of 152.85 €.
